Changmin Park

Title: Changmin Park: Innovator in Pharmaceutical Composition

Introduction

Changmin Park is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Changmin Park holds a patent for an indole carboxamide derivative and a pharmaceutical composition containing the same. This patent describes indole carboxamide compounds of Formula (II) or pharmaceutically acceptable salts that inhibit the production of prostaglandin E (PGE) through the inhibition of microsomal prostaglandin E synthase-1 (mPGES-1). The compounds and their salts are effective in treating or preventing various conditions, including inflammation, arthritis, high fever, pain, cancer, stroke, and brain diseases such as Alzheimer's disease. A pharmaceutical composition that includes the indole carboxamide compound as an active ingredient is also part of this patent.

Career Highlights

Changmin Park is associated with Kukje Pharma Co., Ltd., where he continues to work on innovative pharmaceutical solutions. His research and development efforts have led to advancements in the treatment of serious health conditions.

Collaborations

Changmin has collaborated with notable colleagues, including Younghoon Kim and Juhee Lee, to further enhance the impact of their research in the pharmaceutical industry.

Conclusion

Changmin Park's work in developing indole carboxamide derivatives showcases his commitment to advancing medical science and improving patient outcomes. His contributions are vital in the ongoing fight against various diseases.